The current staging and classification systems of breast cancer and their pitfalls: Is it possible to integrate the complexity of this neoplasm into a unified staging system?

Autor: da Luz, Felipe Andrés Cordero, Araújo, Breno Jeha, de Araújo, Rogério Agenor

Publikováno v: In Critical Reviews in Oncology / Hematology October 2022 178

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Desmoplastic Small Round Cell Tumor: Report of 2 Cases Treated with Chemotherapy Alone or in Combination with Bevacizumab.

Autor: de Araújo, Rogério Agenor, Araújo, Breno Jeha

Publikováno v: Case Reports in Oncology; Jan-Apr2014, Vol. 7 Issue 1, p102-108, 7p

Epidermal growth factor receptor (EGFR) expression in the serum of patients with triple-negative breast carcinoma: prognostic value of this biomarker.

Autor: de Araújo RA; Federal University of Uberlândia, Avenida Pará, Bloco 2U, 1720, Campus Umuarama, Uberlândia, MG, CEP 38400-902, Brazil.; Cancer Research and Prevention Nucleus, Grupo Luta Pela Vida, Cancer Hospital in Uberlândia, Uberlândia, MG, CEP 38405-302, Brazil.; https://orcid.org/0000-0003-4653-6786., da Luz FAC; Cancer Research and Prevention Nucleus, Grupo Luta Pela Vida, Cancer Hospital in Uberlândia, Uberlândia, MG, CEP 38405-302, Brazil.; https://orcid.org/0000-0002-9381-4913., da Costa Marinho E; Cancer Research and Prevention Nucleus, Grupo Luta Pela Vida, Cancer Hospital in Uberlândia, Uberlândia, MG, CEP 38405-302, Brazil.; https://orcid.org/0000-0002-1307-9104., Nascimento CP; Cancer Research and Prevention Nucleus, Grupo Luta Pela Vida, Cancer Hospital in Uberlândia, Uberlândia, MG, CEP 38405-302, Brazil.; https://orcid.org/0000-0002-0955-8559., de Andrade Marques L; Cancer Research and Prevention Nucleus, Grupo Luta Pela Vida, Cancer Hospital in Uberlândia, Uberlândia, MG, CEP 38405-302, Brazil.; https://orcid.org/0000-0002-2734-8352., Delfino PFR; Cancer Research and Prevention Nucleus, Grupo Luta Pela Vida, Cancer Hospital in Uberlândia, Uberlândia, MG, CEP 38405-302, Brazil.; https://orcid.org/0000-0002-2196-9318., Antonioli RM; Cancer Research and Prevention Nucleus, Grupo Luta Pela Vida, Cancer Hospital in Uberlândia, Uberlândia, MG, CEP 38405-302, Brazil.; https://orcid.org/0000-0003-3886-1562., Araújo BJ; São Paulo State Cancer Institute of the Medical School of the University of São Paulo, São Paulo, SP, CEP 38405-302, Brazil.; https://orcid.org/0000-0003-4892-9911., da Silva ACAL; Federal University of Uberlândia, Avenida Pará, Bloco 2U, 1720, Campus Umuarama, Uberlândia, MG, CEP 38400-902, Brazil.; https://orcid.org/0000-0002-8220-938X., Dos Reis Monteiro MLG; Federal University of Uberlândia, Avenida Pará, Bloco 2U, 1720, Campus Umuarama, Uberlândia, MG, CEP 38400-902, Brazil.; https://orcid.org/0000-0002-7961-6996., Neto MB; Department of Basic and Environmental Sciences, University of São Paulo, Lorena, SP, CEP 12602-810, Brazil.; https://orcid.org/0000-0003-4292-7800., Silva MJB; Laboratory of Tumor Biomarkers and Osteoimmunology, Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia, MG, CEP 38405-320, Brazil.; https://orcid.org/0000-0002-5807-4286.

Publikováno v: Ecancermedicalscience [Ecancermedicalscience] 2022 Jul 20; Vol. 16, pp. 1431. Date of Electronic Publication: 2022 Jul 20 (Print Publication: 2022).